HuGE Literature Finder
Records
1
-
3
Anxiety symptom remission is associated with genetic variation of PTPRZ1 among patients with major depressive disorder treated with escitalopram. Pharmacogenetics and genomics 2021 Jun . Su Yun-Ai, Bousman Chad A, Liu Qi, Lv Xiao-Zhen, Li Ji-Tao, Lin Jing-Yu, Yu Xin, Tian Li, Si Tian-M |
No association between the protein tyrosine phosphatase, receptor-type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008 Oct 147B (7): 1013-8. Ito Yoshihito, Yamada Shinnosuke, Takahashi Nagahide, Saito Shinichi, Yoshimi Akira, Inada Toshiya, Noda Yukihiro, Ozaki Nor |
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Molecular psychiatry 2008 Feb 13 (2): 162-72. Buxbaum J D, Georgieva L, Young J J, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock N J, Carroll L, Corfas G, Davis K L, Owen M J, Harroch S, Sakurai T, O'Donovan M |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: